A Multi-Site Study of the Zyga GlyDer Facet Restoration Device In Subjects With LUmbar FacET Pain Syndrome - DUET
Status: | Terminated |
---|---|
Conditions: | Orthopedic |
Therapuetic Areas: | Orthopedics / Podiatry |
Healthy: | No |
Age Range: | 22 - Any |
Updated: | 10/13/2018 |
Start Date: | June 2014 |
End Date: | September 2018 |
A Multi-Site Study of the Zyga GlyDer Facet Restoration Device In Subjects With LUmbar FacET Pain Syndrome (DUET)
A non-randomized, multi-site feasibility study to evaluate the safety of the Glyder Device in
subjects with a history of lumbar facet joint disease (L2 to the sacrum) and successful
neural ablation in which the facet joint is confirmed as the source of pain.
subjects with a history of lumbar facet joint disease (L2 to the sacrum) and successful
neural ablation in which the facet joint is confirmed as the source of pain.
Key Inclusion Criteria:
1. Confirmed bilateral facet joint disease demonstrated by a successful facet rhizotomy
(neural ablation) within 18 months prior to enrollment
2. Facet pain is limited to one to two levels from L2 to the sacrum and pain is bilateral
3. Two diagnostic injections (MBBs) both resulting in 80% relief to confirm back pain is
facetogenic
4. VAS back pain of ≥ 60 mm on a 100 mm scale, and VAS back pain is greater than or equal
to the highest VAS leg pain score
5. ODI ≥ 20 points
6. At least six (6) months of non-operative conservative management (Analgesic therapy
for a minimum of 2 weeks and a minimum of 4 weeks of NSAID therapy; Supervised
exercise and/or physical therapy program-minimum of 12 sessions)
7. At least 22 years of age and skeletally mature
Key Exclusion Criteria:
1. Pain is from a spinal structure other than facet joints (i.e., disc, hip and SI joint
pain are excluded)
2. Osteoporosis or severe osteopenia
3. Lumbar fusion
4. Symptomatic spinal stenosis requiring surgical intervention
5. Prior total disc replacement, fusion, decompressive laminectomy, facetectomy, or
placement of a posterior spinous process device
6. Disc herniation requiring surgical intervention
7. The subject has a Body Mass Index (BMI) of greater than 35
8. Planned elective surgery within 12 months
We found this trial at
4
sites
Tampa, Florida 33607
Principal Investigator: Reginald Davis, MD
Phone: 866-362-7574
Click here to add this to my saved trials

Edmond, Oklahoma 73003
Principal Investigator: Douglas Beall, MD
Phone: 405-601-2325
Click here to add this to my saved trials

Santa Monica, California 90404
Principal Investigator: Hyun Bae, MD
Phone: 310-828-7757
Click here to add this to my saved trials

Spokane, Washington 99208
Principal Investigator: Antoine Tohmeh, MD
Click here to add this to my saved trials
